Prescription GLP-1 drugs themselves cost $245349/month through manufacturer programs, so the supplement line is small, which is exactly why it should be spent on the things that work
In a single piece, he concisely captures: the state of the field the most important clinical trials where the pipeline is headed These Clinical trials are raising the bar and expanding future treatment options: Retatrutide ~24% weight loss (triple agonist) MariTide 1216% weight loss (GLP-1 + GIP antagonist) CagriSema up to 20% weight loss + ~2% HbA1c drop Orforglipron oral GLP-1, HbA1c 1.5%, weight 7.6% IcoSema weekly semaglutide + once-weekly insulin Even more exciting
However, the use of glutamate antagonists as a treatment for PD is still in preliminary stages, as there appears to be negative cognitive effects of such treatment (Nutt et al., 2008)
Your individual treatment duration will align with your health needs and lifestyle
As fat mass decreases, some stored vitamin D may be released, but this does not guarantee adequacy
His clinical background spans more than 15 years across emergency medicine, neurosurgery, hospital medicine, and regenerative medicine, and he personally leads the clinics peptide, hormone, and metabolic care
